Showing results (1911-1920 of 2,085) with videos related to
Sort By:
Pageof 209
Nature Methods|August 1, 2009
Statistical methods for analysis of high-throughput RNA interference screensAmanda Birmingham, Laura M Selfors, Thorsten Forster, et al.Malaria Journal|April 16, 2014
Geographical variation in Plasmodium vivax relapseKatherine E Battle, Markku S Karhunen, Samir Bhatt, et al.Nutrients|December 23, 2022
Food Insecurity in the Rural United States: An Examination of Struggles and Coping Mechanisms to Feed a Family among Households with a Low-IncomeCarmen Byker Shanks, Lauri Andress, Annie Hardison-Moody, et al.American Heart Journal|March 12, 2011
Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapyMiriam Shanks, Victoria Delgado, Arnold C T Ng, et al.Anesthesia and Analgesia|April 15, 2020
Considerations for Integration of Perioperative Electronic Health Records Across Institutions for Research and Quality Improvement: The Approach Taken by the Multicenter Perioperative Outcomes GroupDouglas A Colquhoun, Amy M Shanks, Steven R Kapeles, et al.Molecular Pharmaceutics|December 30, 2015
Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5Amanda Shanks Huynh, Veronica Estrella, Valerie E Stark, et al.American Journal of Perinatology|December 31, 2021
Perinatal Outcomes in Obese Women with One Abnormal Value on 3-Hour Oral Glucose Tolerance TestVictoria R Greenberg, Lisbet S Lundsberg, Uma M Reddy, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2019
An inverse relationship between cortical plasticity and cognitive inhibition in late-life depressionJennifer I Lissemore, Hayley R C Shanks, Meryl A Butters, et al.Antimicrobial Agents and Chemotherapy|January 10, 2018
Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and PreventionGeoffrey W Birrell, Gavin D Heffernan, Guy A Schiehser, et al.Science Translational Medicine|June 12, 2024
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemiaAhmed Khalaf, Lucie de Beauchamp, Eric Kalkman, et al.Pageof 209